Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$231.37 USD
-0.22 (-0.09%)
Updated Jan 27, 2023 04:00 PM ET
After-Market: $229.21 -2.16 (-0.93%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Alnylam Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ALNY 231.37 -0.22(-0.09%)
Will ALNY be a Portfolio Killer in January?
Zacks Investment Research is releasing its prediction for ALNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALNY
Is Nuveen ESG MidCap Growth ETF (NUMG) a Strong ETF Right Now?
Alnylam (ALNY) Posts Strong Preliminary Revenues for 4Q & FY22
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
VERA Dips Despite Positive Data From IgA Nephropathy Study
Clovis (CLVS) Down 18.1% Since Last Earnings Report: Can It Rebound?
Other News for ALNY
Tracking Baillie Gifford`s 13F Portfolio - Q4 2022 Update
Alnylam Pharmaceuticals Larger Than S&P 500 Component Eversource Energy
SVB Securities Keeps Their Hold Rating on Alnylam Pharma (ALNY)
Five Best And Worst Performing Healthcare Stocks In December 2022
Global drug spending to reach $1.9T by 2027 ��� IQVIA